Skip to main content

Expert Insights

Annals of Long-Term Care
Michael Gordon, MD, MSc, FRCPC, discusses his early experiences with electroconvulsive therapy (ECT)—treatment often used for patients with severe depression—and highlights how the balance of antidepressant treatment and ECT has shifted over time to benefit severely depressed older patients.
Annals of Long-Term Care
Brittany H Cone, Esq, and Jordan S Johnson, Esq, attorneys at Hall Booth Smith, PC, talk through the Medicaid program, current practical issues that the long-term care industry is facing, and provide a few possible approaches and solutions to these issues.
Pharmacy Learning Network
In this week’s issue of Talking Therapeutics, Dr Jennings explores the science and promise of a recently approved novel medication for patients with HFrEF.
Veterans Health Today
Victor Murray, Air Force veteran and prostate cancer survivor, explains why he urges Congress to work more with the VA to expand access to high-intensity focused ultrasound and focused ultrasound therapy for America’s veterans.
First Report Managed Care
Carmela Benson, director, real world value & evidence, Janssen Scientific Affairs, LLC, discusses recent research that examined Schizophrenia Population Health Management among adults in order to better understand how population health decision makers prioritize and respond to challenges in…
Integrated Healthcare Executive
Matt Lambert, MD, chief medical officer, Curation Health, discusses why there is a push among many physicians to move to a more value-based care model over a fee-for-service model, explains how he sees care shifting in the future, and provides tips for health care providers looking to move to a…
Annals of Long-Term Care
“Rather than dismissing the fears and concerns of our staff, we need to find ways of addressing the staff where they are,” says Ilene Warner-Maron, PhD. “These concerns cannot be mandated away but must be addressed with empathy, education, and support.”
First Report Managed Care
Annie Yan, PharmD, manager of value & access strategy at Xcenda, a part of AmerisourceBergen, offers insight from study that evaluated payer-initiated oncology pathways, in which trends in utilization, development, and barriers to implementation were measured.
Pharmacy Learning Network
Dr Jennings reviews evidence supporting colchicine use to further reduce residual disease burden in coronary artery disease but highlights why pharmacists need to keep several things in mind when dispensing colchicine to ensure that patients are kept safe.
Annals of Long-Term Care
With several vaccines against COVID-19 already available through emergency use authorization, others potentially on the way, and a nationwide vaccination campaign to administer the vaccine to as many people as quickly possible, the COVID-19 pandemic continues to transition to new phases.
Back to Top